Hormonal induction and roles of disabled-2 in lactation and involution

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Tao, Wensi ^a   Moore, Robert ^a   Smith, Elizabeth R ^a   Xu, Xiang Xi ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ALPHA ADAPTIN; CASPASE 3; CLATHRIN; DISABLED 2 PROTEIN; ESTROGEN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROGESTERONE; PROLACTIN; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; DAB2 PROTEIN, MOUSE; HORMONE; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HORMONAL REGULATION; HORMONE PROTEIN COMPLEX; INTRACELLULAR SIGNALING; INVOLUTION; LACTATION; MOUSE; NONHUMAN; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; ANATOMY AND HISTOLOGY; ANIMAL; CELL PROLIFERATION; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; METABOLISM; ORGAN SIZE; PHYSIOLOGY; PREGNANCY; REPRODUCTION; SIGNAL TRANSDUCTION; UDDER;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; HORMONES; LACTATION; MAMMARY GLANDS, ANIMAL; MICE; ORGAN SIZE; PREGNANCY; REPRODUCTION; SIGNAL TRANSDUCTION;

EID: 84910019792     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110737     Document Type: Article

References (89)

1. Gertler FB, Bennett RL, Clark MJ, Hoffmann FM (1989) Drosophila abl tyrosine kinase in embryonic CNS axons: a role in axonogenesis is revealed through dosage-sensitive interactions with disabled. Cell 58: 103-113.
2. Xu XX, Yang W, Jackowski S, Rock CO (1995) Cloning of a novel phosphoprotein regulated by colony-stimulating factor 1 shares a domain with the Drosophila disabled gene product. J Biol Chem 270: 14184-14191.
3. Xu XX, Yi T, Tang B, Lambeth JD (1998) Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2. Oncogene 16: 1561-1569.
4. Fazili Z, Sun W, Mittelstaedt S, Cohen C, Xu XX (1999) Disabled-2 inactivation is an early step in ovarian tumorigenicity. Oncogene 18: 3104-3113.
5. Howell BW, Hawkes R, Soriano P, Cooper JA (1997) Neuronal position in the developing brain is regulated by mouse disabled-1. Nature 389: 733-737.
6. Mok SC, Wong KK, Chan RK, Lau CC, Tsao SW, et al. (1994) Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. Gynecol Oncol 52: 247-252.
7. Mok SC, Chan WY, Wong KK, Cheung KK, Lau CC, et al. (1998) DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer. Oncogene 16: 2381-2387.
8. Schwahn DJ, Medina D (1998) p96, a MAPK-related protein, is consistently downregulated during mouse mammary carcinogenesis. Oncogene 17: 1173-1178.
9. Bagadi SA, Prasad CP, Srivastava A, Prashad R, Gupta SD, et al. (2007) Frequent loss of Dab2 protein and infrequent promoter hypermethylation in breast cancer. Breast Cancer Res Treat 104: 277-286.
10. Sheng Z, Sun W, Smith E, Cohen C, Xu XX (2000) Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells. Oncogene 19: 4847-4854.
11. Yang DH, Smith ER, Roland IH, Sheng Z, He J, et al. (2002) Disabled-2 is essential for endodermal cell positioning and structure formation during mouse embryogenesis. Dev Biol 251: 27-44.
12. Yang DH, Cai KQ, Roland IH, Smith ER, Xu XX (2007) Disabled-2 is an epithelial surface positioning gene. J Biol Chem 282: 13114-13122.
13. Mishra SK, Keyel PA, Hawryluk MJ, Agostinelli NR, Watkins SC, et al. (2002) Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor. EMBO J 21: 4915-4926.
14. Bork P, Margolis B (1995) A phosphotyrosine interaction domain. Cell 80: 693-694.
15. Traub LM (2003) Sorting it out: AP-2 and alternate clathrin adaptors in endocytic cargo selection. J Cell Biol 163: 203-208.
16. Inoue A, Sato O, Homma K, Ikebe M (2002) DOC-2/DAB2 is the binding partner of myosin VI. Biochem Biophys Res Commun 292: 300-307.
17. Morris SM, Arden SD, Roberts RC, Kendrick-Jones J, Cooper JA, et al. (2002) Myosin VI binds to and localises with Dab2, potentially linking receptor-mediated endocytosis and the actin cytoskeleton. Traffic 3: 331-341.
18. Hasson T (2003) Myosin VI: two distinct roles in endocytosis. J Cell Sci 116: 3453-3461.
19. Chao WT, Kunz J (2009) Focal adhesion disassembly requires clathrin-dependent endocytosis of integrins. FEBS Lett 583: 1337-1343.
20. Chetrit D, Ziv N, Ehrlich M (2009) Dab2 regulates clathrin assembly and cell spreading. Biochem J 418: 701-715.
21. Teckchandani A, Toida N, Goodchild J, Henderson C, Watts J, et al. (2009) Quantitative proteomics identifies a Dab2/integrin module regulating cell migration. J Cell Biol 186: 99-111.
22. He J, Smith ER, Xu XX (2001) Disabled-2 exerts its tumor suppressor activity by uncoupling c-Fos expression and MAP kinase activation. J Biol Chem 276: 26814-26818.
23. Zhou J, Hsieh JT (2001) The inhibitory role of DOC-2/DAB2 in growth factor receptor-mediated signal cascade: DOC-2/DAB2-mediated inhibition of ERK phosphorylation via binding to Grb2. J Biol Chem 276: 27793-27798.
24. Hannigan A, Smith P, Kalna G, Lo Nigro C, Orange C, et al. (2010) Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter. J Clin Invest 120: 2842-2857.
25. Hocevar BA, Smine A, Xu XX, Howe PH (2001) The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway. EMBO J 20: 2789-2801.
26. Hocevar BA, Prunier C, Howe PH (2005) Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway. J Biol Chem 280: 25920-25927.
27. Prunier C, Howe PH (2005) Disabled-2 (Dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (EMT). J Biol Chem 280: 17540-17548.
28. Hocevar BA, Mou F, Rennolds JL, Morris SM, Cooper JA, et al. (2003) Regulation of the Wnt signaling pathway by disabled-2 (Dab2). EMBO J 22: 3084-3094.
29. Jiang Y, Prunier C, Howe PH (2008) The inhibitory effects of Disabled-2 (Dab2) on Wnt signaling are mediated through Axin. Oncogene 27: 1865-1875.
30. Jiang Y, Luo W, Howe PH (2009) Dab2 stabilizes Axin and attenuates Wnt/beta-catenin signaling by preventing protein phosphatase 1 (PP1)-Axin interactions. Oncogene 28: 2999-3007.
31. Jiang Y, He X, Howe PH (2012) Disabled-2 (Dab2) inhibits Wnt/β-catenin signalling by binding LRP6 and promoting its internalization through clathrin. EMBO J 31: 2336-2349.
32. Morris SM, Tallquist MD, Rock CO, Cooper JA (2002) Dual roles for the Dab2 adaptor protein in embryonic development and kidney transport. EMBO J 21: 1555-1564.
33. Waters SB, Yamauchi K, Pessin JE (1995) Insulin-stimulated disassociation of the SOS-Grb2 complex. Mol Cell Biol 15: 2791-2799.
34. Cherniack AD, Klarlund JK, Conway BR, Czech MP (1995) Disassembly of Son-of-seven less proteins from Grb2 during p21ras desensitization by insulin. J Biol Chem 270: 1485-1488.
35. Corbalan-Garcia S, Yang SS, Degenhardt KR, Bar-Sagi D (1996) Identification of the mitogen-activated protein kinase phosphorylation sites on human Sos1 that regulate interaction with Grb2. Mol Cell Biol 16: 5674-5682.
36. Buday L, Warne PH, Downward J (1995) Downregulation of the Ras activation pathway by MAP kinase phosphorylation of Sos. Oncogene 11: 1327-1331.
37. Rozakis-Adcock M, van der Geer P, Mbamalu G, Pawson T (1995) MAP kinase phosphorylation of mSos1 promotes dissociation of mSos1-Shc and mSos1-EGF receptor complexes. Oncogene 11: 1417-1426.
38. Porfiri E, McCormick F (1996) Regulation of epidermal growth factor receptor signaling by phosphorylation of the ras exchange factor hSOS1. J Biol Chem 271: 5871-5877.
39. Richert MM, Schwertfeger KL, Ryder JW, Anderson SM (2000) An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia 5: 227-241.
40. Brisken C, O'Malley B (2010) Hormone action in the mammary gland. Cold Spring Harb Perspect Biol 2:a003178.
41. Neville MC, McFadden TB, Forsyth I (2002) Hormonal regulation of mammary differentiation and milk secretion. J Mammary Gland Biol Neoplasia 7: 49-66.
42. Dickson RB, Lippman ME (1988) Control of human breast cancer by estrogen, growth factors, and oncogenes. Cancer Treat Res 40: 119-165.
43. LaMarca HL, Rosen JM (2007) Estrogen regulation of mammary gland development and breast cancer: amphiregulin takes center stage. Breast Cancer Res 9: 304.
44. Howlin J, McBryan J, Martin F (2006) Pubertal mammary gland development: insights from mouse models. J Mammary Gland Biol Neoplasia 11: 283-297.
45. Watson CJ, Khaled WT (2008) Mammary development in the embryo and adult: a journey of morphogenesis and commitment. Development 135: 995-1003.
46. Furth PA (1999) Introduction: mammary gland involution and apoptosis of mammary epithelial cells. J Mammary Gland Biol Neoplasia 4: 123-127.
47. Stein T, Salomonis N, Gusterson BA (2007) Mammary gland involution as a multi-step process. J Mammary Gland Biol Neoplasia 12: 25-35.
48. Bierie B, Gorska AE, Stover DG, Moses HL (2009) TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involution. J Cell Physiol 219: 57-68.
49. Furth PA, Bar-Peled U, Li M (1997) Apoptosis and mammary gland involution: reviewing the process. Apoptosis 2: 19-24.
50. Heermeier K, Benedict M, Li M, Furth P, Nuñez G, et al. (1996) Bax and Bcl-xs are induced at the onset of apoptosis in involuting mammary epithelial cells. Mech Dev 56: 197-207.
51. Li M, Liu X, Robinson G, Bar-Peled U, Wagner KU, et al. (1997) Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc Natl Acad Sci U S A 94: 3425-3430.
52. Li M, Hu J, Heermeier K, Hennighausen L, Furth PA (1996) Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways. Cell Growth Differ 7: 13-20.
53. Schorr K, Li M, Krajewski S, Reed JC, Furth PA (1999) Bcl-2 gene family and related proteins in mammary gland involution and breast cancer. J Mammary Gland Biol Neoplasia 4: 153-164.
54. Schorr K, Li M, Bar-Peled U, Lewis A, Heredia A, et al. (1999) Gain of Bcl-2 is more potent than bax loss in regulating mammary epithelial cell survival in vivo. Cancer Res 59: 2541-2545.
55. Sutherland KD, Lindeman GJ, Visvader JE (2007) The molecular culprits underlying precocious mammary gland involution. J Mammary Gland Biol Neoplasia 12: 15-23.
56. Moore R, Cai KQ, Tao W, Smith ER, Xu XX (2013) Differential requirement for Dab2 in the development of embryonic and extra-embryonic tissues. BMC Dev Biol 13: 39.
57. Tallquist MD, Soriano P (2000) Epiblast-restricted cre expression in MORE mice: a tool to distinguish embryonic vs. extra-embryonic gene function. Genesis 26: 113-115.
58. Hayashi S, Tenzen T, McMahon AP (2003) Maternal inheritance of Cre activity in a Sox2Cre deleter strain. Genesis 37: 51-53.
59. Barcellos-Hoff MH, Aggeler J, Ram TG, Bissell MJ (1989) Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development 105: 223-235.
60. Chlon TM, Taffany DA, Welsh J, Rowling MJ (2008) Retinoids modulate expression of the endocytic partners megalin, cubilin, and disabled-2 and uptake of vitamin D-binding protein in human mammary cells. J Nutr 138: 1323-1328.
61. - mice. Am J Physiol Renal Physiol 301:F1105-1113.
62. Antalffy G, Caride AJ, Pászty K, Hegedus L, Padanyi R, et al. (2011) Apical localization of PMCA2w/b is enhanced in terminally polarized MDCK cells. Biochem Biophys Res Commun 410: 322-327.
63. Nguyen AV, Pollard JW (2000) Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development 127: 3107-3118.
64. Flanders KC, Wakefield LM (2009) Transforming growth factor-(beta)s and mammary gland involution; functional roles and implications for cancer progression. J Mammary Gland Biol Neoplasia 14: 131-144.
65. Kelsey JL, Gammon MD (1991) The epidemiology of breast cancer. CA Cancer J Clin 41: 146-165.
66. Newcomb PA (1997) Lactation and breast cancer risk. J Mammary Gland Biol Neoplasia 2: 311-318.
67. Medina D (2004) Breast cancer: the protective effect of pregnancy. Clin Cancer Res 10: 380S-384S.
68. Radisky DC, Hartmann LC (2009) Mammary involution and breast cancer risk: transgenic models and clinical studies. J Mammary Gland Biol Neoplasia 14: 181-191.
69. Russo IH, Russo J (2007) Primary prevention of breast cancer by hormone-induced differentiation. Recent Results Cancer Res 174: 111-130.
70. Sivaraman L, Medina D (2002) Hormone-induced protection against breast cancer. J Mammary Gland Biol Neoplasia 7: 77-92.
71. Russo IH, Russo J (2008) Use of human chorionic gonadotropin in the prevention of breast cancer. Womens Health (Lond Engl) 4: 1-5.
72. Monks J, Henson PM (2009) Differentiation of the mammary epithelial cell during involution: implications for breast cancer. J Mammary Gland Biol Neoplasia 14: 159-170.
73. Sheng Z, He J, Tuppen JA, Sun W, Fazili Z, et al. (2000) Structure, sequence, and promoter analysis of human disabled-2 gene (DAB2). Genomics, 70: 381-386.
74. Sheng Z, Smith ER, He J, Tuppen JA, Martin WD, et al. (2001) Chromosomal location of murine disabled-2 gene and structural comparison with its human ortholog. Gene 268: 31-39.
75. Beato M (1989) Gene regulation by steroid hormones. Cell 56: 335-344.
76. Sun J, Nawaz Z, Slingerland JM (2007) Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen-responsive elements in breast cancer cells. Mol Endocrinol 21: 2651-2662.
77. Heldin CH, Miyazono K, Dijke P ten (1997) TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471.
78. Mulder KM (2000) Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 11: 23-35.
79. Guo X, Wang XF (2009) Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 19: 71-88.
80. Lee MK, Pardoux C, Hall MC, Lee PS, Warburton D, et al. (2007) TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J 26: 3957-3967.
81. Moustakas A, Heldin CH (2005) Non-Smad TGF-beta signals. J Cell Sci 118: 3573-3584.
82. Parvani JG, Taylor MA, Schiemann WP (2011) Noncanonical TGF-β signaling during mammary tumorigenesis. J Mammary Gland Biol Neoplasia 16: 127-146.
83. Zhang YE (2009) Non-Smad pathways in TGF-beta signaling. Cell Res 19: 128-139.
84. Funaba M, Zimmerman CM, Mathews LS (2002) Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase. J Biol Chem 277: 41361-41368.
85. Heide LP van der, Dinther M van, Moustakas A, Dijke P ten (2011) TGFbeta activates mitogen- and stress-activated protein kinase-1 (MSK1) to attenuate cell death. J Biol Chem 286: 5003-5011.
86. Balmanno K, Cook SJ (2009) Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ 16: 368-377.
87. Boucher MJ, Morisset J, Vachon PH, Reed JC, Lainé J, et al. (2000) MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J Cell Biochem 79: 355-369.
88. Sandahl M, Hunter DM, Strunk KE, Earp HS, Cook RS (2010) Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation. BMC Dev Biol 10: 122.
89. Massagué J (2012) TGFβ signalling in context. Nat Rev Mol Cell Biol 13: 616-630.